デフォルト表紙
市場調査レポート
商品コード
907990

ラボインフォマティクスの世界市場

Laboratory Informatics

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.66円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

ラボインフォマティクスの世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のラボインフォマティクス (検査室向けインフォマティクス) 市場について分析し、全体的な市場規模の実績値・予測値や、主な市場促進・抑制要因、展開方式別・エンドユース別および企業別の市場シェア動向 (過去9年間・今後8年間分)、今後の市場成長の方向性、各地域・主要国の市場の詳細動向などを調査すると共に、主要企業のプロファイルなどの情報を取りまとめてお届けいたします。

第1章 分析手法

第2章 エグゼクティブ・サマリー

  • 市場概要
  • 代表的企業の分析
  • 市場の動向と促進要因
  • 世界市場の将来展望
    • 市場規模・シェアの動向見通し:地域別/国別
    • 展開方式別
      • オンプレミス
      • クラウドベース
      • リモートホスト
        • 市場規模:地域別/国別 (過去9年間・今後8年間分)
        • 市場シェア:地域別/国別 (通算17年間分)
    • エンドユース別
      • 製薬/バイオテクノロジー企業
      • バイオバンク・バイオレポジトリ
      • 分子診断、臨床試験室
      • 医薬品開発/製造業務受託機関 (CRO/CMO)
      • 教育・研究機関
        • 市場規模:地域別/国別 (過去9年間・今後8年間分)
        • 市場シェア:地域別/国別 (通算17年間分)

第3章 市場分析

  • 地域別の市場分析
  • 米国
    • 市場の基本データ
    • 企業別市場シェア
    • ラボインフォマティクスの市場規模 (実績値・予測値)
    • 展開方式別の市場規模 (実績値・予測値)
    • エンドユース別の市場規模 (実績値・予測値)
  • カナダ
  • 日本
  • 中国
  • 欧州 (フランス、ドイツ、イタリア、英国など)
  • アジア太平洋地域
  • 他の国々 (RoW)

第4章 企業

  • ABBOTT INFORMATICS (Abbott Laboratoriesの子会社)
  • AGILENT TECHNOLOGIES
  • ARXSPAN, LLC
  • AUTOSCRIBE INFORMATICS, INC.
  • DASSAULT SYSTeMES
  • ID BUSINESS SOLUTIONS LTD. (IDBS)
  • KINEMATIK
  • LABVANTAGE SOLUTIONS
  • LABLYNX
  • LABWARE
  • LABWORKS
  • PERKINELMER
  • RURO
  • THERMO FISHER SCIENTIFIC
  • WATERS CORPORATION

第5章 関連分析

目次
Product Code: MCP12927

Abstract:

Global Laboratory Informatics Market to Reach $3.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Laboratory Informatics estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. On-Premise, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cloud-based segment is readjusted to a revised 5.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $750.5 Million, While China is Forecast to Grow at 4.7% CAGR

The Laboratory Informatics market in the U.S. is estimated at US$750.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$632.4 Million by the year 2027 trailing a CAGR of 4.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Remotely-hosted Segment to Record 5.8% CAGR

In the global Remotely-hosted segment, USA, Canada, Japan, China and Europe will drive the 5.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$412.7 Million in the year 2020 will reach a projected size of US$614.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$411.1 Million by the year 2027.

Select Competitors (Total 43 Featured) -

  • Abbott Informatics
  • Agilent Technologies, Inc.
  • Arxspan, LLC
  • Autoscribe Informatics, Inc.
  • Bio-ITech BV
  • Bytewize AB
  • Dassault Systemes
  • ID Business Solutions Ltd. (IDBS)
  • iVention B.V.
  • KineMatik Ltd.
  • Lablynx, Inc.
  • Labvantage Solutions, Inc.
  • LabWare, Inc.
  • Labworks LLC.
  • PerkinElmer, Inc.
  • RURO, Inc.
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Laboratory Informatics: An Introduction
    • Outlook
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • New Lab Informatics Trends
    • Rise in Integration of Informatics in Life Science Laboratories
    • Research Focus Grows on User-Centered Design
    • Informatics Approaches to In Silico Drug Discovery
    • AI in Drug Discovery and Application of Informatics
    • Centralized Data Management and Impact on Lab Informatics
    • A Peek into Changes in Laboratory
    • Accelerating Digital Transformation in Laboratories to Benefit Demand
    • Importance of Digital pharmaceutical laboratory
    • Benefits Of Cloud-Based Platforms For Laboratory Informatics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Laboratory Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Laboratory Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Laboratory Informatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cloud-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Remotely-hosted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Remotely-hosted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Remotely-hosted by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Biobanks & Biorepositories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Biobanks & Biorepositories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Biobanks & Biorepositories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Molecular Diagnostics & Clinical Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Molecular Diagnostics & Clinical Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Molecular Diagnostics & Clinical Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Contract Services Organizations (CROs & CMOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Contract Services Organizations (CROs & CMOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Contract Services Organizations (CROs & CMOs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • COMPETITION

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 40: Japan Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 43: Japan Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 46: China Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 49: China Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: China Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: China 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 52: Europe Current & Future Analysis for Laboratory Informatics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Laboratory Informatics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Laboratory Informatics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 58: Europe Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Europe Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Europe 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 61: France Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 64: France Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: France Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: France 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 67: Germany Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 70: Germany Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Germany Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Germany 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 73: Italy Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 76: Italy Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Italy Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Italy 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 79: UK Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 82: UK Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: UK Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: UK 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 85: Rest of Europe Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Europe 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 88: Rest of Europe Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Rest of Europe Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Rest of Europe 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 91: Asia-Pacific Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Asia-Pacific 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 94: Asia-Pacific Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Asia-Pacific Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Asia-Pacific 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 97: Rest of World Current & Future Analysis for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World Historic Review for Laboratory Informatics by Deployment - On-Premise, Cloud-based and Remotely-hosted Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of World 15-Year Perspective for Laboratory Informatics by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud-based and Remotely-hosted for the Years 2012, 2020 & 2027
    • TABLE 100: Rest of World Current & Future Analysis for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Rest of World Historic Review for Laboratory Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Rest of World 15-Year Perspective for Laboratory Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Biobanks & Biorepositories, Molecular Diagnostics & Clinical Research Laboratories, Contract Services Organizations (CROs & CMOs) and Academic Research Institutes for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 43